Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment vs ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-Insured
NAV, returns and costs — not a recommendation.
 Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment |  ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-Insured | |
|---|---|---|
| NAV | ₹11.776 | ₹43.43 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +19.86% | +7.31% |
| 3 year (p.a.) | +10.48% | +22.09% |
| 5 year (p.a.) | +10.48% | +15.97% |
| Expense ratio | 2.09% | 1.56% |
| Fund size | ₹332.52 Cr | ₹6,624.58 Cr |
| Risk | — | Very high |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.